Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

Added 217 days ago (28.04.2021)
Authors: A Cozzi-Lepri; R Zangerle; L Machala; K Zilmer; M Ristola; C Pradier; O Kirk; H Sambatakou; G Fätkenheuer; I Yust; P Schmid; M Gottfredsson; I Khromova; D Jilich; R Flisiak; J Smidt; B Rozentale; R Radoi; M H Losso; J D Lundgren; A Mocroft; EuroSIDA Study Group
Read article